The effects of hormone replacement therapy on lipid peroxidation and antioxidant status

Maturitas

Volumn 38, Issue 2, 2001, Pages 165-170

  Özden, Serin ^a   Dildar, Konukoǧlu ^b   Kadir, Yelke Hakan ^b   Gülizar, Kuǧu ^a  

^a Taksim State Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Glutathione; Glutathione peroxidase; Hormone replacement therapy; Lipid peroxidation

Indexed keywords

CONJUGATED ESTROGEN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MEDROXYPROGESTERONE ACETATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; NORMAL HUMAN; PLASMA; POSTMENOPAUSE;

CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HORMONE REPLACEMENT THERAPY; HUMANS; LIPID PEROXIDATION; MIDDLE AGED; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0035917938     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00216-4     Document Type: Article

References (33)

1. Estrogen and coronary heart disease in women
2. Menopause and the risk of cardiovascular disease: The Framingham Study
3. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence
4. Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins
5. Estrogen and progestin, lipoprotein (a) and the risk of recurrent coronary heart disease events after menopause
6. Postmenopausal use of estrogen and occlusion of coronary arteries
7. Cardiovascular mortality and non-contraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
8. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
9. Postmenopausal hormone therapy increases risk of venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study
10. The role of free radicals in toxicity and disease
11. Red cell peroxide metabolism in diabetes mellitus
12. Microsomal lipid peroxidation
13. Improved method for determination of blood glutathione
14. Studies on the quantitative and qualitative characterization of glutathione peroxidase
15. International Committee for Standardization in Haematology (ICSH): Recommendations for reference method for haemoglobinometry in human blood (ICSH standard 1986] and specifications for international haemoglobincyanide reference preparation
16. Cardioprotection by estrogens: Mechanisms of action - The lipids
17. Oestrogens and atherosclerotic vascular disease - Lipid factors
18. Cardiovascular effects and estrogen/gestagen substition therapy
19. Lipid peroxidation and its role in atherosclerosis
20. The susceptibility to auto-oxidation of human red cell lipids in health and disease
21. Estrogens inhibit copper and cell-mediated modification of low-density lipoprotein
22. Antioxidant potential of specific estrogens on lipid peroxidation
23. Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women
24. Effects of hormone replacement therapy on lipid peroxides and oxidation system in postmenopausal women
25. Estrogens as natural antioxidants of membrane phospholipid peroxidation
26. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens
27. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
28. Blood flow
29. Are the antioxidative effects of 17β-estradiol modified by concomitant administration of a progestin?
30. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants
31. Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
32. Atherosclerosis or lipoprotein-induced endothelial dysfunction: Potential mechanisms underlying reduction in EDRF/nitric oxide activity
33. Effects of hormone replacement therapy on plasma nitric oxide and total thiol levels in postmenopausal women